A case of primary hyperaldosteronism due to an adrenal adenoma with near syncope and torsade de pointes is described. A woman patient had a history of high blood pressure and severe hypokalemia that was the cause of her ventricular arrhythmia, which was controlled by administering potassium supplementation but no antiarrhythmic medication. Adrenal adenoma was identified on axial computerized tomography. This case report suggests that there may be a chance of complete cure from torsade de pointes if the underlying cause of QT prolongation can be identified.
Get full access to this article
View all access options for this article.
References
1.
Dunnick NR, Leight GS, Roubidoux MA, et al: CT in the diagnosis of primary aldosteronism:sensitivity in 29 patients. Am J Roentgenol160:321-324, 1993.
2.
Krikler DM, Curry Pvl: Torsade de pointes, an atypical ventricular tachycardia. Br Heart J38:117-120, 1976.
3.
Sanderson JE , Cockram CS, Yu CM, et al: Myocardial fibrosis and hyperaldosteronism . Eur Heart J17:1761-1762, 1996 .
4.
Weber KT, Brilla CG, Campbell SE, et al: Pathologic hypertrophy with fibrosis: The structural basis for myocardial failure. Blood Press1:75-85, 1992.
5.
Potts JL, Dalakos TG, Streeten Dhp, et al: Cardiomyopathy in an adult with Bartter's syndrome and hypokalemia . Am J Cardiol40:995-999, 1977.
6.
Surawicz B.: Relation between electrocardiogram and electrolytes. Am Heart J73:814-834, 1967.
7.
Lehmann MH, Hardy S., Archibald D., et al: Sex differences in risk of torsade de pointes with d,l-sotalol . Circulation94:2535-2541, 1996 .
8.
Gettes L., Surawicz B.: Effects of low and high concentrations of potassium on the simultaneously recorded Purkinje and ventricular action potentials of the perfused pig moderator band. Circ Res23:717-729,1968.
9.
Roden DM, Iansmith Dhs: Effects of low potassium or magnesium concentrations on isolated cardiac tissue . Am J Med82(suppl 3A):18-23, 1987.
10.
Curry P., Stubbs W., Fitchett D., et al: Ventricular arrhythmias and hypokalemia. Lancet2:231-233, 1976.
11.
Commerford PJ, Lloyd EA: Arrhythmias in patients with drug toxicity, electrolyte and endocrine disturbances. Med Clin North Am68:1051-1078, 1984.
12.
Fish C.: Relation of electrolyte disturbance to cardiac arrhythmias. Circulation47:408-419, 1973.
13.
Roden DM: Magnesium treatment of ventricular arrhythmias. Am J Cardiol63:43G-46G, 1989.
14.
Tzivoni D., Keren A.: Suppression of ventricular arrhythmias by magnesium. Am J Cardiol65 :1397-1399, 1990.
15.
Iseri LT: Role of magnesium in cardiac tachyarrhythmias. Am J Cardiol65:47K-50K, 1990.
16.
Whang R., Morosi HJ, Rodgers D., et al: The influence of continuing magnesium deficiency on muscle potassium repletion. J Lab Clin Med70:895-902, 1967.
17.
Skou J.: The influence of some cations on an adenosine triphosphatase from peripheral nerves. 1957. Biochim Biophys Acta1000:439-46, 1989.